# Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke

> **NCT05604638** · PHASE3 · RECRUITING · sponsor: **Second Affiliated Hospital of Guangxi Medical University** · enrollment: 348 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Tirofiban Hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05604638
- **Lead sponsor:** Second Affiliated Hospital of Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-24
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 348 (ESTIMATED)
- **Last updated:** 2025-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05604638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05604638, "Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05604638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*